ASX:BIOHousehold & Personal ProductsPersonal Care Products

BIOME AUSTRALIA ORD

$0.340
Day Range
$0.325 - $0.340
52 Week Range
$0.305 - $0.630
Volume
93.62K
Avg Volume (10D)
209.04K
Market Cap
$77.18M
P/E Ratio
336.73
Price Chart
Market Statistics
Open$0.335
Previous Close$0.340
Day High$0.340
Day Low$0.325
52 Week High$0.630
52 Week Low$0.305
Valuation
Market Cap77.18M
Shares Outstanding227.00M
P/E Ratio (Annual)336.73
P/E Ratio (TTM)78.57
Price to Book12.12
Trading Activity
Volume93.62K
Value Traded30.98K
Bid$0.325 × 101,149
Ask$0.340 × 18,571
Performance
1 Day4.76%
5 Day4.76%
13 Week-18.52%
52 Week-32.65%
YTD-21.43%
Technical Indicators
RSI (14)41.06
50-Day SMA$0.403
200-Day SMA$0.458
Latest News
Biome Australia Expands Retail Distribution with Mecca and Go Vita Partnerships
Biotechnology

Biome Australia Expands Retail Distribution with Mecca and Go Vita Partnerships

Biome Australia (ASX: BIO) has struck new distribution agreements with Mecca and Go Vita, marking a significant expansion for its flagship Activated Probiotics range into both premium beauty and mainstream health food retail. The company said the partnerships represent a turning point in its distribution strategy, extending reach into high-traffic retail environments while reinforcing its […]

1 min read
Nik Hill
Nik Hill
Market wrap: Australia ignores Wall Street record on faltering miners
Hot Topics

Market wrap: Australia ignores Wall Street record on faltering miners

The Australian share market once again ignored a rally on Wall Street to a fresh record high and closed down 0.3% thanks to a broad-based slump on Friday. It was yet another reminder of how the Australian bourse with its heavy concentration of miners and banks has disconnected from the Artificial Intelligence rally that is […]

7 min read
John Beveridge
John Beveridge
Biome Australia expects to surpass FY24 earnings guidance on back of record sales revenue
Biotechnology

Biome Australia expects to surpass FY24 earnings guidance on back of record sales revenue

Biome Australia (ASX: BIO) is on target to easily beat its 2024 financial year forecast after a strong period of revenue. The microbiome health specialist had predicted FY2024 earnings of $12.5 million but record sales numbers for April and May have increased expectations. This follows the company’s initial $11.5m estimate announced in October 2023 being […]

1 min read
Colin Hay
Colin Hay
Market wrap: ASX 200 dips slightly despite energy rally
Hot Topics

Market wrap: ASX 200 dips slightly despite energy rally

Despite a continuing rally for energy stocks on the back of a rising oil price, the Australian share market fell a little lower, following a volatile day on Wall Street. The energy sector was up 0.5% following rising oil prices which spiked to US$79 a barrel after the US and UK launched airstrikes on Houthi […]

5 min read
John Beveridge
John Beveridge